Concepedia

Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials

Teny Grace Skaria, Anu Sreeprakash, Rashwith Umesh, Sneha Joseph, Manju Mohan, Sakir Ahmed, Pankti Mehta, Seena Elsa Oommen, Jannet Benny, Anagha Paulose,

The Lancet Rheumatology · 2022 · 29 citations · 22 references

DOIFull text

Open access

Concepts

References

22

2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative

Daniel Aletaha, Tuhina Neogi, Alan J. Silman et al. · Arthritis & Rheumatism · 2010 · 9.6K citations · Full text

, , +13

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

, , +17

Classification criteria for psoriatic arthritis: Development of new criteria from a large international study

William J. Taylor, Dafna D. Gladman, Philip Helliwell et al. · Arthritis & Rheumatism · 2006 · 3.7K citations

, , +16

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Victoria Furer, Tali Eviatar, Devy Zisman et al. · Annals of the Rheumatic Diseases · 2021 · 691 citations · Full text

, , +15

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

Rebecca H. Haberman, Ramin S. Herati, David Simón et al. · Annals of the Rheumatic Diseases · 2021 · 266 citations · Full text

, , +16